July 5, 2024
1 min read

Tagworks expands management team

We are pleased to announce the appointment of Bianca Matthee as our VP of Research Operations.
Ms. Matthee brings nearly 20 years of experience in the operational realization of corporate strategy in biotech/pharma. She has filled line- and program leadership positions in businesses of various sizes and has advised multiple biotech firms as an independent consultant. Before joining Tagworks, she was COO at Hybridize Therapeutics, VP Manufacturing & Pharmaceutics at ProQR and she held positions in R&D at CureVac (Frame), Johnson & Johnson (Crucell) and Merck, Sharp & Dome (Organon, Schering Plough).

The expertise of Ms. Matthee supports the ambition of Tagworks Pharmaceuticals to grow and to change the standard of care for patients suffering from severe diseases including cancer by building a pipeline of first-in-class Click-to-Release therapeutics.

We feel privileged to welcome Bianca to our company !

Curious about what we do? Get in touch!


About    Our Technology   Pipeline    Join us    News    Contact

T +31 85 800 8550

Tagworks Pharmaceuticals BV
Toernooiveld 1
6525 ED  Nijmegen
The Netherlands

Stay updated

© Tagworks Pharmaceuticals, 2024 | Terms of use | Design by Ape to Zebra